Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Orvosi Hetilap|March 26, 2023
[Pediatric cardiopulmonary resuscitation]Gyula Tövisházi, Katalin Csordás, Balázs Hauser
Orvosi Hetilap|September 28, 2011
[Pharmacokinetic analysis of high-dose methotrexate treatments in children with hematologic malignancies]Katalin Csordás, Olivér Eipel, Márta Hegyi, et al.
The Pediatric Infectious Disease Journal|May 13, 2025
Rotavirus Hepatitis in Pediatric Hematopoietic Stem Cell Transplant RecipientsGabriella Kertész, Zsófia Szkiba, Katalin Csordás, et al.
Orvosi Hetilap|July 4, 2017
[Changes in diagnostic criteria of thrombotic microangiopathy after stem cell transplantation]Orsolya Horváth, Zoltán Prohászka, Krisztián Kállay, et al.
Journal of Pediatric Hematology/Oncology|April 7, 2016
Some GCR Polymorphisms (N363S, ER22/23EK, and Bcl-1) May Influence Steroid-induced Toxicities and Survival Rates in Children With ALLOliver Eipel, Márta Hegyi, Katalin Csordás, et al.
BMC Medical Education|December 6, 2019
The timing of testing influences skill retention after basic life support training: a prospective quasi-experimental studyEnikő Kovács, Zsigmond Máté Jenei, Katalin Csordás, et al.
Pathology Oncology Research : POR|March 11, 2018
Antithymocyte Globuline Therapy and Bradycardia in ChildrenKrisztián Kállay, Dávid Zakariás, Katalin Csordás, et al.
Children (Basel, Switzerland)|May 1, 2025
Real World Posaconazole Pharmacokinetic Data in Paediatric Stem Cell Transplant RecipientsCsaba Kassa, Katalin Csordás, Lídia Hau, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 18, 2018
Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell TransplantationOrsolya Horváth, Krisztián Kállay, Dorottya Csuka, et al.
Pageof 2